Evidence map›Paper›PMID 28363520›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2017

Sequence segregation improves non-covalent protein delivery.

Federica Sgolastra, Coralie M Backlund, E Ilker Ozay, Brittany M deRonde, Lisa M Minter, Gregory N Tew

Abstract read
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Targeting the Inside of Cells with Biologicals: Chemicals as a Delivery Strategy.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2021
    Review
  6. Article
  7. A Novel Cre Recombinase-MediatedApplied and environmental microbiology · 2019
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Federica SgolastraDepartment of Polymer Science & Engineering, University of Massachusetts, Amherst, MA 01003, United States.
Coralie M BacklundDepartment of Polymer Science & Engineering, University of Massachusetts, Amherst, MA 01003, United States.
E Ilker OzayMolecular and Cellular Biology Program, University of Massachusetts, Amherst, MA 01003, United States.
Brittany M deRondeDepartment of Polymer Science & Engineering, University of Massachusetts, Amherst, MA 01003, United States.
Lisa M MinterMolecular and Cellular Biology Program, University of Massachusetts, Amherst, MA 01003, United States; Department of Veterinary & Animal Sciences, University of Massachusetts, Amherst, MA 01003, United States.
Gregory N TewDepartment of Polymer Science & Engineering, University of Massachusetts, Amherst, MA 01003, United States; Molecular and Cellular Biology Program, University of Massachusetts, Amherst, MA 01003, United States; Department of Veterinary & Animal Sciences, University of Massachusetts, Amherst, MA 01003, United States. Electronic address: tew@mail.pse.umass.edu.
University of Massachusetts Amherst · US

Funding

Targeting y-secretase in GVHDP01CA166009 · NCI · UNIVERSITY OF MASSACHUSETTS AMHERST · PI OSBORNE, BARBARA A · 2013 to 2017
$4.9M
CHEMISTRY-BIOLOGY INTERFACE PREDOCTORAL TRAINING GRANTST32GM008515 · NIGMS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI THOMPSON, LYNMARIE K. · 1995 to 2020
$4.3M
NCI NIH HHS P01 CA166009NIGMS NIH HHS T32 GM008515
6 · The paper itself

Abstract

The impermeability of the plasma membrane towards large, hydrophilic biomolecules is a major obstacle in their use and development against intracellular targets. To overcome such limitations, protein transduction domains (PTDs) have been used as protein carriers, however they often require covalent fusion to the protein for efficient delivery. In an effort to develop more efficient and versatile biological vehicles, a series of PTD-inspired polyoxanorbornene-based synthetic mimics with identical chemical compositions but different hydrophobic/hydrophilic segregation were used to investigate the role of sequence segregation on protein binding and uptake into Jurkat T cells and HEK293Ts. This series was composed of a strongly segregated block copolymer, an intermediately segregated gradient copolymer, and a non-segregated homopolymer. Among the series, the block copolymer maximized both protein binding and translocation efficiencies, closely followed by the gradient copolymer, resulting in two protein transporter molecules more efficacious than currently commercially available agents. These two polymers were also used to deliver the biologically active Cre recombinase into a loxP-reporter T cell line. Since exogenous Cre must reach the nucleus and retain its activity to induce gene recombination, this in vitro experiment better exemplifies the broad applicability of this synthetic system. This study shows that increasing segregation between hydrophobic and cationic moieties in these polymeric mimics improves non-covalent protein delivery, providing crucial design parameters for the creation of more potent biological delivery agents for research and biomedical applications.

Indexed as

Biological TransportDrug CarriersDrug LiberationHEK293 CellsHumansHydrophobic and Hydrophilic InteractionsIntegrasesJurkat CellsNorbornanesPeptidesPermeabilityPolymersProtein BindingProtein ConformationProtein DomainsProteinsCre recombinaseDrug CarriersIntegrasesNorbornanesPeptidesPolymersProteinsCell penetrating peptidesNon-covalent protein deliveryPep-1Protein bindingProtein transduction domain mimicsSequence segregation

Identifiers

PMID28363520
PMCPMC5568762
OpenAlexW2600588343

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.